PHGE
PHGE
AMEX · Biotechnology

Biomx Inc

$0.15
-0.01 (-5.10%)
As of Aug 14, 10:26 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +14,274.1% upside
Low Target $13.63
Average Target $21.13
High Target $23.51
Current Price $0.15
Current
$0.15
Target
$21.13
$13.63 $21.13 avg $23.51
Scenario Analysis
Bear Case
$13.63
9,172.1%
Low target
Base Case
$21.13
+14,274.1%
Avg target
Bull Case
$23.51
+15,893.2%
High target
Risk/Reward
1.7x
Balanced
Price in Context
Target vs 52W High
$21.13
+54.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%